Logo
i

iHeart Japan Corporation

8 employees

iHeart Japan is developing regenerative medicinal products for severe heart failure, using iPSC technologies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
regenerative medicine
biotechnology
Nursing and Residential Care
Medical
cell therapy

Date founded

2013

Funding rounds raised

Total raised

$6.4M

from 3 investors over 3 rounds

i

iHeart Japan Corporation raised $6.4M on May 16, 2016

Investors: SBI Investment and Real Tech Holdings Co.,Ltd.

i

iHeart Japan Corporation raised $1.9M on September 1, 2014

Investors: Miyako Capital

FAQ